08 ottobre 2024 (09:15 - 13:00 CEST)

Unlocking potential in Life Sciences: collaborative research between Academia and Industry in Europe
 

HUMAN TECHNOPOLE V.le Rita Levi-Montalcini, 1 - 20157, MILANO

Daniela Bellomo

OSPEDALE SAN RAFFAELE, Director Business Development and Technology Transfer Division

Elisabetta Confalonieri

General Manager DG University, Research, Innovation, Lombardy Region

Fabrizio Conicella

CHIESI FARMACEUTICI, Vice President - Center of Open Innovation & Competence

Alessandro Curioni

IBM RESEARCH – ZURICH, IBM fellow, VP Europe and Africa and Director

Fabrizio Grillo

Director General Affairs & International Relations, Bracco Group

David Hulcoop

CEO, Open Targets

Bert Klebl

LEAD DISCOVERY CENTER, Managing Director and Chief Scientific Officer

Marica Nobile

FEDERCHIMICA ASSOBIOTEC, Director

Corrado Panzeri

THE EUROPEAN HOUSE - AMBROSETTI, Partner e Responsabile Innovation & Technology Hub

Francesca Pasinelli

FONDAZIONE TELETHON, Deputy Board Member

Maria Cristina Porta

General Manager, ENEA Tech e Biomedical

Fabio Terragni

FONDAZIONE HUMAN TECHNOPOLE, Member of the Management Committee delegate for technology transfer

Gianmario Verona

FONDAZIONE HUMAN TECHNOPOLE, President

Marino Zerial

FONDAZIONE HUMAN TECHNOPOLE, Director

The process of technology transfer in the Life Sciences aims to advance early scientific inventions and discoveries to the next generation of diagnostics, therapies, services, and enterprises. Because of its intrinsic attitude to risk, hypothesis-driven research, and data sharing, academia produces a large amount of highly valuable discoveries and inventions that, regrettably, do not always translate into therapies and products beneficial for society. Indeed, the journey from academic research to patients requires competencies, know-how, and access to considerable scientific, human, and economic resources. Academia spin-offs and start-ups often lack the resources and know-how to tackle these challenges. On the other hand, the industry has been thriving in delivering breakthrough therapies and diagnostic tools to patients while not being as effective as academia in producing breakthrough scientific discoveries. Collaboration between academia and industry is essential to unlock the full potential of both worlds, and Europe hosts several examples of such collaborations.
With this in mind, we would like to gather some of the key players in the Italian Life Science ecosystem to discuss such European examples and join efforts to build a model for Italy.